Trials / Completed
CompletedNCT02462070
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and efficacy of a topical lotion.
Detailed description
The objective of the study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult subjects with moderate to severe plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-118 Lotion | Lotion |
| DRUG | IDP-118 Vehicle Lotion | Lotion |
Timeline
- Start date
- 2015-08-11
- Primary completion
- 2016-11-08
- Completion
- 2016-12-01
- First posted
- 2015-06-03
- Last updated
- 2020-08-20
- Results posted
- 2020-08-20
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02462070. Inclusion in this directory is not an endorsement.